https://www.healthtimesvirginislands.com/article/910796897-latest-pharmaceutical-suppositories-market-size-to-hit-usd-13-4-bn-at-a-cagr-of-3-5-by-2034-report-by-zion-market-research Health Times Virgin Islands en PressRelease 2026-05-06T12:41:14+00:00 [Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.healthtimesvirginislands.com/article/910796652-where-executives-are-doubling-down-on-their-companies-fortunes Health Times Virgin Islands en PressRelease 2026-05-06T12:35:00+00:00 Where Executives Are Doubling Down on Their Companies’ Fortunes https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://www.healthtimesvirginislands.com/article/910796841-ernexa-therapeutics-unveils-breakthrough-preclinical-results-erna-101-achieves-100-survival-and-complete-tumor-elimination-in-ovarian-cancer-models Health Times Virgin Islands en PressRelease 2026-05-06T12:33:00+00:00 Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.healthtimesvirginislands.com/article/910795980-bioxodes-presents-positive-final-phase-2a-intracerebral-hemorrhage-results-at-esoc-affirming-breakthrough-potential-of-biox-101 Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101 https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png https://www.healthtimesvirginislands.com/article/910796094-pliant-therapeutics-to-participate-in-the-rbc-capital-markets-global-healthcare-conference Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.healthtimesvirginislands.com/article/910796098-veru-to-report-fiscal-2026-second-quarter-financial-results-on-may-13th Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th https://ml.globenewswire.com/media/9c96f1a7-e104-47d4-8011-8c19496681c2/small/final-veruinclogo-rgb-300dpi-jpg.jpg https://www.healthtimesvirginislands.com/article/910796167-allogene-therapeutics-to-report-first-quarter-financial-results-and-provide-business-update Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.healthtimesvirginislands.com/article/910796329-cristcot-appoints-rayna-herman-as-president-of-its-hydrocortisone-acetate-commercial-division Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division https://ml.globenewswire.com/media/ODc0YjM4OTItZWNkZi00ZWU2LThmY2QtYTFhZGNiMmFjMTE4LTEzMjI0MTAtMjAyNi0wNS0wNi1lbg==/tiny/Cristcot-LLC.png https://www.healthtimesvirginislands.com/article/910796657-oncotelic-therapeutics-announces-closing-of-a-strategic-monetization-of-its-cns-nasal-assets-with-lunai-bioworks-advancing-joint-development-in Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.healthtimesvirginislands.com/article/910796713-cdt-advances-azd5904-into-global-patent-phase-and-initiates-partnering-discussions Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions https://ml.globenewswire.com/media/Y2YxYWQ5NTgtMDg3ZC00NGRlLTlkMmItODk2Zjk4YTAxYTg4LTEyNzQxMDItMjAyNi0wNS0wNi1lbg==/tiny/CDT-Equity-Inc-.png https://www.healthtimesvirginislands.com/article/910796774-crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910796861-inflarx-announces-pricing-of-150-million-underwritten-offering-of-ordinary-shares Health Times Virgin Islands en PressRelease 2026-05-06T12:30:00+00:00 InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.healthtimesvirginislands.com/article/910796856-inflarx-announces-advancement-of-izicopan-in-anca-associated-vasculitis-and-select-renal-diseases Health Times Virgin Islands en PressRelease 2026-05-06T12:25:00+00:00 InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.healthtimesvirginislands.com/article/910796721-scienture-announces-third-patent-grant-for-arbli-losartan-potassium-oral-suspension-strengthening-long-term-market-exclusivity-through-2041 Health Times Virgin Islands en PressRelease 2026-05-06T12:05:00+00:00 SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 https://ml.globenewswire.com/media/492f1bb3-8792-47f3-81e5-15dd04df46b4/small/logo-png.png https://www.healthtimesvirginislands.com/article/910796254-orchestra-biomed-receives-15-million-investment-from-ligand-under-previously-announced-strategic-financing-agreement Health Times Virgin Islands en PressRelease 2026-05-06T12:01:00+00:00 Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.healthtimesvirginislands.com/article/910796015-aktis-oncology-to-present-at-the-bofa-securities-health-care-conference Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Aktis Oncology to Present at the BofA Securities Health Care Conference https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.healthtimesvirginislands.com/article/910796024-abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors https://ml.globenewswire.com/media/b771ed66-3175-44f5-be35-7c3c380f64a1/small/abli-tx-jpg.jpg https://www.healthtimesvirginislands.com/article/910796040-annexon-to-present-at-the-bank-of-america-securities-health-care-conference-2026 Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Annexon to Present at the Bank of America Securities Health Care Conference 2026 https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://www.healthtimesvirginislands.com/article/910796051-in8bio-to-showcase-next-generation-t-cell-engager-platform-and-new-clinical-data-at-upcoming-r-d-day-and-medical-conferences Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://www.healthtimesvirginislands.com/article/910796111-pathos-ai-acquires-majority-stake-in-deuteroncology-to-advance-next-generation-met-inhibitor-identified-by-pathos-foundry-platform Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform https://ml.globenewswire.com/media/3a9007f6-d394-44fa-adf5-606bbb9d5d85/small/pr-image-png.png https://www.healthtimesvirginislands.com/article/910796113-milestone-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://www.healthtimesvirginislands.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.healthtimesvirginislands.com/article/910796216-rhythm-pharmaceuticals-announces-participation-in-upcoming-bank-of-america-global-healthcare-conference Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.healthtimesvirginislands.com/article/910796223-orchestra-biomed-receives-20-million-payment-from-medtronic-under-previously-announced-financing-agreement Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.healthtimesvirginislands.com/article/910796232-urogen-reports-zusduri-revenue-more-than-doubled-quarter-over-quarter-and-provides-first-quarter-2026-financial-results-and-highlights Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png https://www.healthtimesvirginislands.com/article/910796338-pds-biotech-announces-conference-call-and-webcast-for-2026-first-quarter-financial-results Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results https://ml.globenewswire.com/media/e2e7d124-dbd4-4140-9cc5-449d3488a902/small/pds-biotech-logo-png.png https://www.healthtimesvirginislands.com/article/910796344-crysvita-now-publicly-reimbursed-for-the-treatment-of-adults-with-xlh-in-four-provinces-and-federal-non-insured-health-benefits-program Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program https://ml.globenewswire.com/media/a3a8a24d-ccff-49c4-baf1-bf8e8a7a2551/small/img-ogp-1755267550540-png.png https://www.healthtimesvirginislands.com/article/910796347-crysvita-mc-est-d-sormais-rembours-par-les-r-gimes-publics-pour-le-traitement-des-adultes-atteints-d-xlh-dans-quatre-provinces-et-dans-le-cadre-du Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 CRYSVITA(MC) est désormais remboursé par les régimes publics pour le traitement des adultes atteints d’XLH dans quatre provinces et dans le cadre du Programme fédéral des services de santé non assurés https://ml.globenewswire.com/media/a3a8a24d-ccff-49c4-baf1-bf8e8a7a2551/small/img-ogp-1755267550540-png.png https://www.healthtimesvirginislands.com/article/910796373-erasca-to-present-at-the-bank-of-america-securities-health-care-conference Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Erasca to Present at the Bank of America Securities Health Care Conference https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://www.healthtimesvirginislands.com/article/910796402-brain-cancer-canada-awards-75-000-to-groundbreaking-pediatric-brain-cancer-study-at-university-of-manitoba-targeting-hard-to-treat-dmg-p-tumours Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.healthtimesvirginislands.com/article/910796679-polypid-to-report-first-quarter-2026-financial-results-and-operational-highlights-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-06T12:00:00+00:00 PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026 https://ml.globenewswire.com/media/202fc254-aac1-49c2-a08d-cc0efc938460/small/polypid-logo-final-rgb-2x-100-jpg.jpg https://www.healthtimesvirginislands.com/article/910784580-kura-oncology-to-participate-in-bank-of-america-securities-healthcare-conference Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Kura Oncology to Participate in Bank of America Securities Healthcare Conference https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.healthtimesvirginislands.com/article/910784610-beyonttra-acoramidis-the-first-near-complete-ttr-stabilizer-90-approved-by-anvisa-to-treat-attr-cm-in-brazil Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthtimesvirginislands.com/article/910784618-medicus-pharma-announces-results-from-pre-specified-expanded-phase-2-sknjct-003-data-analysis-demonstrating-positive-dose-response Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.healthtimesvirginislands.com/article/910784675-cronos-expands-pre-roll-portfolio-with-spinach-stix Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Cronos Expands Pre-Roll Portfolio with Spinach STIX® https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://www.healthtimesvirginislands.com/article/910784783-bioventus-reports-first-quarter-financial-results Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Bioventus Reports First Quarter Financial Results https://ml.globenewswire.com/media/e10db184-593a-40b5-af02-627c27583108/small/bioventus-logo-png.png https://www.healthtimesvirginislands.com/article/910784806-medline-reports-first-quarter-2026-results Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Medline Reports First Quarter 2026 Results https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://www.healthtimesvirginislands.com/article/910784827-immusoft-to-present-data-highlighting-positive-results-from-the-world-s-first-engineered-b-cell-in-a-human-clinical-trial-at-asgct-2026 Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026 https://ml.globenewswire.com/media/4a461fce-d4b2-46be-b0e5-da2737c3eb90/small/immusoft-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910784844-altimmune-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.healthtimesvirginislands.com/article/910784933-briacell-receives-fda-clearance-to-initiate-bria-bres-clinical-study-in-breast-cancer Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer https://ml.globenewswire.com/media/cf1af19a-fd92-49b4-8e39-fb9b1c4191a7/medium/figure-1.jpg https://www.healthtimesvirginislands.com/article/910785001-crescent-biopharma-to-present-at-may-investor-conferences Health Times Virgin Islands en PressRelease 2026-05-06T11:30:00+00:00 Crescent Biopharma to Present at May Investor Conferences https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.healthtimesvirginislands.com/article/910785004-lifecore-biomedical-reports-financial-results-for-the-first-quarter-ended-march-31-2026-and-provides-corporate-update Health Times Virgin Islands en PressRelease 2026-05-06T11:05:00+00:00 Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png https://www.healthtimesvirginislands.com/article/910784577-immunocore-reports-first-quarter-financial-results-and-provides-a-business-update Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Immunocore reports first quarter financial results and provides a business update https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png https://www.healthtimesvirginislands.com/article/910784599-kymera-therapeutics-to-participate-in-upcoming-may-investor-conferences Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Kymera Therapeutics to Participate in Upcoming May Investor Conferences https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.healthtimesvirginislands.com/article/910784602-relmada-therapeutics-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026 Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 https://ml.globenewswire.com/media/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a/small/relmada-logo-png.png https://www.healthtimesvirginislands.com/article/910784604-aquestive-therapeutics-to-report-first-quarter-2026-financial-results-and-recent-business-highlights-on-may-13-and-host-conference-call-on-may-14-at Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET https://ml.globenewswire.com/media/e0b65f93-9565-43d7-a6ff-88b8cbd6adea/small/aquestive-jpg.jpg https://www.healthtimesvirginislands.com/article/910784613-kamada-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/6334b598-e958-4ac2-b196-aac2c24ea458/small/picture1-jpg.jpg https://www.healthtimesvirginislands.com/article/910784623-tscan-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/d8d2632e-0ce4-4ed2-940e-22a1c599d43f/small/tscan-logo-png.png https://www.healthtimesvirginislands.com/article/910784703-eyepoint-reports-first-quarter-2026-financial-results-and-highlights-recent-corporate-developments Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://www.healthtimesvirginislands.com/article/910784717-biocryst-reports-first-quarter-2026-financial-results-and-provides-business-update Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910784760-geron-corporation-reports-first-quarter-2026-financial-results-and-recent-business-highlights Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910784850-madrigal-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910784964-tonix-pharmaceuticals-secures-commercial-payer-coverage-for-tonmya-providing-access-for-35-million-u-s-patients Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.healthtimesvirginislands.com/article/910784982-tempest-presents-clinical-update-at-isct-2026-annual-meeting Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Tempest Presents Clinical Update at ISCT 2026 Annual Meeting https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.healthtimesvirginislands.com/article/910784997-anavex-life-sciences-board-of-directors-appoints-former-senior-vice-president-of-clinical-development-terrie-kellmeyer-phd-as-interim-chief Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png https://www.healthtimesvirginislands.com/article/910785011-eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b-2a-resolve-trial-in-eosinophilic-esophagitis-at-digestive Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.healthtimesvirginislands.com/article/910785064-hyperion-defi-announces-pricing-of-public-offering-of-common-stock Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 Hyperion DeFi Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910785142-tg-therapeutics-reports-first-quarter-2026-financial-results-and-raises-briumvi-revenue-guidance Health Times Virgin Islands en PressRelease 2026-05-06T11:00:00+00:00 TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.healthtimesvirginislands.com/article/910772607-mannkind-announces-ralinepag-dry-powder-inhalation-dpi-program-to-be-pursued-for-pulmonary-hypertension-and-fibrotic-lung-diseases Health Times Virgin Islands en PressRelease 2026-05-06T10:30:00+00:00 MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.healthtimesvirginislands.com/article/910772795-recursion-reports-first-quarter-financial-results-and-provides-business-update Health Times Virgin Islands en PressRelease 2026-05-06T10:30:00+00:00 Recursion Reports First Quarter Financial Results and Provides Business Update https://ml.globenewswire.com/media/d2751ce2-f602-4ebf-b6b6-8acff83456f5/medium/recursions-wholly-owned-pipeline.jpg https://www.healthtimesvirginislands.com/article/910772628-people-living-with-cancer-caregivers-urge-congress-to-expand-access-to-whole-person-supportive-cancer-care-as-part-of-national-summit Health Times Virgin Islands en PressRelease 2026-05-06T10:00:00+00:00 People Living with Cancer, Caregivers Urge Congress to Expand Access to Whole-Person Supportive Cancer Care As Part of National Summit https://ml.globenewswire.com/media/NjdlODk0YzAtNDZmNS00YmU0LWFmMjItZDk0MDc1OTc3ZmFhLTUwMDE2MjE3My0yMDI2LTA1LTA2LWVu/tiny/The-Sheri-and-Les-Biller-Famil.png https://www.healthtimesvirginislands.com/article/910772798-aclarion-announces-inducement-grant-to-new-commercial-director-western-u-s Health Times Virgin Islands en PressRelease 2026-05-06T10:00:00+00:00 Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.healthtimesvirginislands.com/article/910730182-immutrin-appoints-leading-cardiovascular-drug-development-expert-dr-robert-blaustein-as-chief-medical-officer-and-establishes-us-subsidiary Health Times Virgin Islands en PressRelease 2026-05-06T06:00:00+00:00 Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary https://ml-eu.globenewswire.com/media/b8f96d3c-b61d-4f73-8c17-929d628c2984/small/image-2immutrin-jpg.jpg https://www.healthtimesvirginislands.com/article/910730186-avacta-presents-new-comparisons-of-pre-cision-payload-release-vs-approved-adcs-and-ava6207-dual-payload-delivery-at-science-day-2026 Health Times Virgin Islands en PressRelease 2026-05-06T06:00:00+00:00 Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://www.healthtimesvirginislands.com/article/910719259-philips-delivers-strong-order-intake-comparable-sales-growth-and-margin-expansion-in-q1-2026-outlook-reiterated Health Times Virgin Islands en PressRelease 2026-05-06T05:00:00+00:00 Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.healthtimesvirginislands.com/article/910696959-avalo-therapeutics-announces-pricing-of-375-million-public-offering Health Times Virgin Islands en PressRelease 2026-05-06T03:33:54+00:00 Avalo Therapeutics Announces Pricing of $375 Million Public Offering https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.healthtimesvirginislands.com/article/910696876-lbl-047-prioritized-for-clinical-development-in-sj-gren-s-disease-systemic-lupus-erythematosus-and-dermatomyositis Health Times Virgin Islands en PressRelease 2026-05-06T02:57:21+00:00 LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis https://ml.globenewswire.com/media/YjZkMjQxNjctYjA3Ni00YmZkLThkMGMtZDhmZTMzNGI3ZTMxLTEzMDgzODktMjAyNi0wNS0wNi1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://www.healthtimesvirginislands.com/article/910686158-writeupp-introduces-embedded-ai-medical-scribe-with-soap-dap-and-birp-note-generation-at-ca-40-per-user Health Times Virgin Islands en PressRelease 2026-05-06T02:45:54+00:00 WriteUpp Introduces Embedded AI Medical Scribe With SOAP, DAP and BIRP Note Generation at CA$40 Per User https://ml.globenewswire.com/media/a75e2abd-2872-4427-9104-2e700e6a8340/medium/writeupp-introduces-embedded-ai-medical-scribe-with-soap-dap.png https://www.healthtimesvirginislands.com/article/910661966-rapid-nutrition-enhances-investor-access-with-agentic-ai-driven-on-demand-communication-platform Health Times Virgin Islands en PressRelease 2026-05-06T00:27:06+00:00 Rapid Nutrition Enhances Investor Access with Agentic AI driven On-Demand Communication Platform https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.healthtimesvirginislands.com/article/910636745-isothrive-reports-highly-statistically-significant-phase-2-data-for-mhs-1031-in-nerd-patients-at-ddw-2026 Health Times Virgin Islands en PressRelease 2026-05-05T22:16:13+00:00 ISOThrive Reports Highly Statistically Significant Phase 2 Data for MHS-1031 in NERD Patients at DDW 2026 https://ml.globenewswire.com/media/bbf9967c-a7fb-4fa6-b7e7-3cab0c0479b9/medium/cover-image.jpg https://www.healthtimesvirginislands.com/article/910624511-biomea-fusion-announces-poster-presentations-of-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions Health Times Virgin Islands en PressRelease 2026-05-05T21:50:41+00:00 Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions https://ml.globenewswire.com/media/d2f051eb-da8d-4233-9093-8ff1579d035f/small/biomea-fusion-logo-rgb-rev2-email-png.png https://www.healthtimesvirginislands.com/article/910624458-mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Health Times Virgin Islands en PressRelease 2026-05-05T21:34:32+00:00 Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910624423-epik-biosciences-launches-to-pioneer-ketamine-powered-psychedelic-therapies-to-transform-treatment-of-mental-health-pain-and-addiction Health Times Virgin Islands en PressRelease 2026-05-05T21:20:00+00:00 EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction https://ml.globenewswire.com/media/3ffb3db0-76c3-46ee-84b6-368a18fbeefc/small/epik-png.png https://www.healthtimesvirginislands.com/article/910612410-aura-biosciences-announces-closing-of-299-million-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares Health Times Virgin Islands en PressRelease 2026-05-05T21:15:00+00:00 Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.healthtimesvirginislands.com/article/910611978-steris-announces-dividend-of-0-63-per-share Health Times Virgin Islands en PressRelease 2026-05-05T20:30:00+00:00 STERIS Announces Dividend of $0.63 per share https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.healthtimesvirginislands.com/article/910612071-theriva-biologics-reports-first-quarter-2026-operational-highlights-and-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:30:00+00:00 Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910612085-fda-expands-market-access-authorizes-new-ends-products Health Times Virgin Islands en PressRelease 2026-05-05T20:27:48+00:00 FDA Expands Market Access, Authorizes New ENDS Products https://ml.globenewswire.com/media/YjBiNDNiOTUtOGFkYi00NDg0LTlhYmMtYzJjNWJlNjIxNmY2LTUwMDE1NDE1NC0yMDI2LTA1LTA1LWVu/tiny/FDA.png https://www.healthtimesvirginislands.com/article/910612052-pacira-biosciences-mails-letter-to-stockholders Health Times Virgin Islands en PressRelease 2026-05-05T20:20:00+00:00 Pacira BioSciences Mails Letter to Stockholders https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.healthtimesvirginislands.com/article/910599747-longeveron-to-report-2026-first-quarter-financial-results-and-host-conference-call-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-05T20:15:00+00:00 Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026 https://ml.globenewswire.com/media/a6d6e61c-2a7d-4b22-954b-04b9841fbc38/small/longeveron-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599971-sienna-reports-first-quarter-2026-financial-results-and-continues-platform-expansion Health Times Virgin Islands en PressRelease 2026-05-05T20:15:00+00:00 Sienna Reports First Quarter 2026 Financial Results and Continues Platform Expansion https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Health Times Virgin Islands en PressRelease 2026-05-05T20:15:00+00:00 Cytokinetics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.healthtimesvirginislands.com/article/910599138-onkure-therapeutics-reports-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 OnKure Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b01f7b95-9b60-4b2b-8515-fe0cae183fff/small/onkure-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599159-sana-biotechnology-to-present-at-the-bofa-securities-2026-healthcare-conference Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg https://www.healthtimesvirginislands.com/article/910599164-spero-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599178-korro-to-participate-in-upcoming-investor-conferences Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Korro to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910599236-alamar-biosciences-to-participate-in-bofa-securities-2026-healthcare-conference Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://www.healthtimesvirginislands.com/article/910599247-trevi-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599249-adaptive-biotechnologies-reports-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Adaptive Biotechnologies Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.healthtimesvirginislands.com/article/910599357-myriad-genetics-reports-first-quarter-2026-financial-results-reiterates-2026-financial-guidance-reflecting-ongoing-progress-in-the-cancer-care Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.healthtimesvirginislands.com/article/910599397-iridex-to-report-first-quarter-2026-financial-results-on-may-19-2026 Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg https://www.healthtimesvirginislands.com/article/910599618-amwell-announces-results-for-first-quarter-2026 Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Amwell® Announces Results for First Quarter 2026 https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://www.healthtimesvirginislands.com/article/910599661-avalo-therapeutics-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.healthtimesvirginislands.com/article/910599743-innovage-announces-financial-results-for-the-fiscal-third-quarter-ended-march-31-2026 Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910599766-standard-biotools-reports-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Standard BioTools Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png https://www.healthtimesvirginislands.com/article/910599869-relay-therapeutics-reports-first-quarter-2026-financial-results-and-corporate-updates Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.healthtimesvirginislands.com/article/910600015-supernus-announces-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Supernus Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://www.healthtimesvirginislands.com/article/910600051-lemaitre-q1-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 LeMaitre Q1 2026 Financial Results https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910600067-verrica-pharmaceuticals-announces-upcoming-presentation-of-phase-2-data-highlighting-the-potential-abscopal-effects-of-vp-315-in-the-treatment-of Health Times Virgin Islands en PressRelease 2026-05-05T20:05:00+00:00 Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting  https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599241-carlsmed-reports-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Carlsmed® Reports First Quarter 2026 Financial Results  https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png https://www.healthtimesvirginislands.com/article/910599255-dianthus-therapeutics-highlights-recent-business-achievements-and-reports-q1-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png https://www.healthtimesvirginislands.com/article/910599363-monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://www.healthtimesvirginislands.com/article/910599377-avalyn-to-present-patient-centered-research-on-ap01-delivery-and-supportive-care-experiences-at-american-thoracic-society-2026-international Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.healthtimesvirginislands.com/article/910599422-praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.healthtimesvirginislands.com/article/910599496-ligand-to-participate-in-may-investor-conferences Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Ligand to Participate in May Investor Conferences https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.healthtimesvirginislands.com/article/910599599-ultragenyx-reports-first-quarter-2026-financial-results-and-corporate-update Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://www.healthtimesvirginislands.com/article/910599621-dentsply-sirona-reports-first-quarter-2026-results Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Dentsply Sirona Reports First Quarter 2026 Results https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG https://www.healthtimesvirginislands.com/article/910599629-avalo-therapeutics-achieves-positive-topline-results-in-phase-2-lotus-trial-of-abdakibart-avtx-009-in-moderate-to-severe-hidradenitis-suppurativa Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.healthtimesvirginislands.com/article/910599881-hyperion-defi-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910599936-healthequity-announces-first-quarter-earnings-release-date-and-investor-conference-schedule Health Times Virgin Islands en PressRelease 2026-05-05T20:01:00+00:00 HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule https://ml.globenewswire.com/media/30a1510d-03b1-4356-b38d-e9f75f1ec797/small/healthequitylogo-purple-2020-jpg.jpg https://www.healthtimesvirginislands.com/article/910599226-acumen-pharmaceuticals-to-report-first-quarter-financial-results-on-may-12-2026 Health Times Virgin Islands en PressRelease 2026-05-05T20:00:00+00:00 Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://www.healthtimesvirginislands.com/article/910599338-inmune-bio-and-anthony-nolan-announce-strategic-expansion-of-cordstrom-msc-platform-collaboration-to-target-rdeb-oncology-and-inflammatory-diseases Health Times Virgin Islands en PressRelease 2026-05-05T20:00:00+00:00 INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.healthtimesvirginislands.com/article/910587066-context-by-fulcra-dynamics-launches-updated-version-2-4-7-now-with-the-capacity-for-groups Health Times Virgin Islands en PressRelease 2026-05-05T19:22:00+00:00 Context, by Fulcra Dynamics, Launches Updated Version 2.4.7 - Now With the Capacity for Groups https://pressranger.s3.us-west-1.amazonaws.com/3254028/active_tab.png https://www.healthtimesvirginislands.com/article/910587060-neuvasq-presents-data-showcasing-promising-novel-multispecific-gpr124-targeting-antibodies-for-blood-retina-barrier-restoration-at-arvo-2026 Health Times Virgin Islands en PressRelease 2026-05-05T19:15:00+00:00 Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026 https://ml.globenewswire.com/media/758fbb1f-ac3c-4f37-ba02-64c0f59beff0/small/neuvasq-logo-png-png.png https://www.healthtimesvirginislands.com/article/910576181-sk-pharmteco-obtient-la-validation-de-la-sbti-pour-ses-objectifs-scientifiques-de-neutralit-carbone-horizon-2040 Health Times Virgin Islands en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco obtient la validation de la SBTi pour ses objectifs scientifiques de neutralité carbone à horizon 2040 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthtimesvirginislands.com/article/910576183-sk-pharmteco-erh-lt-sbti-validierung-f-r-wissenschaftsbasierte-netto-null-ziele-bis-2040 Health Times Virgin Islands en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco erhält SBTi-Validierung für wissenschaftsbasierte Netto-Null-Ziele bis 2040 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthtimesvirginislands.com/article/910576185-sk-pharmteco-2040-sbti Health Times Virgin Islands en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco, 2040년 넷제로 과학 기반 목표에 대한 글로벌 기후변화 대응 이니셔티브 (SBTi) 검증 획득 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthtimesvirginislands.com/article/910576128-the-association-of-american-physicians-and-surgeons-files-in-the-u-s-supreme-court-in-opposition-to-mifepristone-abortion-by-mail Health Times Virgin Islands en PressRelease 2026-05-05T18:15:52+00:00 The Association of American Physicians and Surgeons Files in the U.S. Supreme Court in Opposition to Mifepristone Abortion-by-Mail https://ml.globenewswire.com/media/NThiZDE0ODctMDBhNC00N2UzLTkzZmMtNDUwYzc2ZTU0MjkzLTEwMzM1MTctMjAyNi0wNS0wNS1lbg==/tiny/Association-of-American-Physic.png https://www.healthtimesvirginislands.com/article/910565807-mesa-laboratories-inc-to-announce-fourth-quarter-and-full-fiscal-year-results-on-may-27-2026 Health Times Virgin Islands en PressRelease 2026-05-05T17:39:00+00:00 Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 https://ml.globenewswire.com/media/ff66b401-9246-47b9-accc-2f553d346c5c/small/mesalogo-jpg.jpg https://www.healthtimesvirginislands.com/article/910565759-hantavirus-cluster-linked-to-cruise-ship-highlights-ongoing-zoonotic-risk-and-the-need-for-vigilance Health Times Virgin Islands en PressRelease 2026-05-05T17:20:00+00:00 Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.healthtimesvirginislands.com/article/910565666-ergodyne-mips-bring-another-head-protection-first-to-worksites Health Times Virgin Islands en PressRelease 2026-05-05T17:15:00+00:00 Ergodyne + Mips Bring Another Head Protection First to Worksites https://ml.globenewswire.com/media/NGEwMDhhNTMtYmMwNC00ODBmLWJiMGItMmMzNjU3MWQ4MjdlLTExODg4MTAtMjAyNi0wNS0wNS1lbg==/tiny/Ergodyne.png https://www.healthtimesvirginislands.com/article/910565583-smith-nephew-drives-progress-in-chronic-wound-care-with-allevyn-complete-care-dressing-and-renasys-edge-tnpwt-set-to-launch-at-ewma-2026 Health Times Virgin Islands en PressRelease 2026-05-05T17:00:00+00:00 Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026 https://ml-eu.globenewswire.com/media/8512c693-36e3-49c5-9341-0e33875d614d/small/s-n-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910565607-scilex-holding-company-announces-its-subsidiaries-acea-therapeutics-inc-and-acea-pharma-inc-entered-into-a-definitive-agreement-with-phoenix Health Times Virgin Islands en PressRelease 2026-05-05T17:00:00+00:00 Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910555990-american-nurses-association-calls-for-nurse-led-guardrails-on-artificial-intelligence-in-healthcare Health Times Virgin Islands en PressRelease 2026-05-05T16:46:15+00:00 American Nurses Association Calls for Nurse-Led Guardrails on Artificial Intelligence in Healthcare https://ml.globenewswire.com/media/ZmJhMWViYzAtNWRmOS00MDI4LThjMGEtNGFiODlhNzc2ZjZjLTUwMDE2MTk2Mi0yMDI2LTA1LTA1LWVu/tiny/American-Nurses-Enterprise.png https://www.healthtimesvirginislands.com/article/910545481-valneva-to-report-first-quarter-2026-consolidated-financial-results-on-may-13-2026 Health Times Virgin Islands en PressRelease 2026-05-05T15:45:00+00:00 Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://www.healthtimesvirginislands.com/article/910545482-valneva-publiera-ses-r-sultats-financiers-consolid-s-du-premier-semestre-le-13-mai-2026 Health Times Virgin Islands en PressRelease 2026-05-05T15:45:00+00:00 Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://www.healthtimesvirginislands.com/article/910545526-allsup-named-usa-today-s-top-workplace-third-year-in-a-row Health Times Virgin Islands en PressRelease 2026-05-05T15:27:44+00:00 Allsup Named USA Today’s Top Workplace Third Year In A Row https://ml.globenewswire.com/media/OTVmNmRkNjctYjAzMC00Y2M3LTg2OTktODg4ZmQ5NjYxOTYxLTEwOTcwODEtMjAyNi0wNS0wNS1lbg==/tiny/Allsup.png https://www.healthtimesvirginislands.com/article/910545507-correction-genembryomics-and-genomic-prediction-launch-xgen-pgt-x Health Times Virgin Islands en PressRelease 2026-05-05T15:08:38+00:00 CORRECTION: GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™ https://ml.globenewswire.com/media/ODM4NWIzMDItOGZhNy00ZTgyLWI5YTctNzE1NWI3MTk3MDU0LTEzMjMxNzktMjAyNi0wNS0wNS1lbg==/tiny/Genomic-Prediction.png https://www.healthtimesvirginislands.com/article/910545505-wellspan-health-opens-carlisle-hospital-expanding-emergency-care-in-a-growing-cumberland-county-corridor Health Times Virgin Islands en PressRelease 2026-05-05T15:07:16+00:00 WellSpan Health opens Carlisle hospital, expanding emergency care in a growing Cumberland County corridor https://ml.globenewswire.com/media/ZjI3MjljNTgtODgzMi00MGQ3LWJhMTQtZWFhNjVmMWZhZTRmLTEyMjE1MzQtMjAyNi0wNS0wNS1lbg==/tiny/WellSpan-Health.png https://www.healthtimesvirginislands.com/article/910536173-canadian-soccer-standout-cloey-uddenberg-and-team-physician-dr-kevin-asem-join-lung-health-foundation-s-national-push-to-keep-kids-with-asthma-in-the Health Times Virgin Islands en PressRelease 2026-05-05T15:00:00+00:00 Canadian Soccer Standout Cloey Uddenberg and Team Physician Dr. Kevin Asem Join Lung Health Foundation’s National Push to Keep Kids with Asthma in the Game https://ml.globenewswire.com/media/8463bfc8-e43b-49db-bf75-f2e28ae429c6/medium/play-prepared-ambassadors.jpg https://www.healthtimesvirginislands.com/article/910536165-atos-and-cna-strengthen-long-term-strategic-partnership-through-new-multi-year-infrastructure-services-agreement Health Times Virgin Islands en PressRelease 2026-05-05T14:49:42+00:00 Atos and CNA strengthen long-term strategic partnership through new multi-year infrastructure services agreement https://ml.globenewswire.com/media/3eacc37c-6163-4d11-95aa-944fca92da46/small/atos-logo-blue-rgb-png.png https://www.healthtimesvirginislands.com/article/910536118-the-matcha-tokyo-brings-premium-japanese-matcha-culture-to-toronto-s-ossington-strip-with-first-canadian-location-opening-may-16 Health Times Virgin Islands en PressRelease 2026-05-05T14:45:27+00:00 The Matcha Tokyo Brings Premium Japanese Matcha Culture to Toronto’s Ossington Strip with First Canadian Location Opening May 16 https://ml.globenewswire.com/media/Y2FiOWM5NDQtOTdkNy00ODEzLTlhN2UtZGEyZGUzMDMwZmI3LTUwMDE2MTk4NS0yMDI2LTA1LTA1LWVu/tiny/The-Matcha-Tokyo.png https://www.healthtimesvirginislands.com/article/910535873-global-sleep-apnea-devices-market-projected-to-exceed-usd-11-61-billion-by-2032-marketsandmarkets Health Times Virgin Islands en PressRelease 2026-05-05T14:45:00+00:00 Global Sleep Apnea Devices Market Projected to Exceed USD 11.61 Billion by 2032 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.healthtimesvirginislands.com/article/910536062-your-medicare-roadmap-what-to-know-before-you-turn-65 Health Times Virgin Islands en PressRelease 2026-05-05T14:27:56+00:00 Your Medicare Roadmap: What to Know Before You Turn 65 https://ml.globenewswire.com/media/e29e0200-7282-4635-af4f-01abe250557e/small/feature-impact-editorlogin-logo2026-png.png https://www.healthtimesvirginislands.com/article/910526322-new-aua-census-shows-shifts-in-urology-workforce-practice-workloads-and-ai-use Health Times Virgin Islands en PressRelease 2026-05-05T14:02:00+00:00 New AUA Census Shows Shifts in Urology Workforce, Practice Workloads and AI Use https://ml.globenewswire.com/media/YWMwNjQ1Y2UtNjlmNy00MTUxLTkxMzQtYjBiNzFiNGJhNDQ5LTEyNzYxOTAtMjAyNi0wNS0wNS1lbg==/tiny/American-Urological-Associatio.png https://www.healthtimesvirginislands.com/article/910526620-lighthouse-autism-center-opening-new-autism-therapy-center-in-council-bluffs-iowa Health Times Virgin Islands en PressRelease 2026-05-05T14:00:29+00:00 Lighthouse Autism Center Opening New Autism Therapy Center in Council Bluffs, Iowa https://ml.globenewswire.com/media/e432b138-98bf-4971-921d-61bc5ac70fa7/small/lighthouse-primary-png.png https://www.healthtimesvirginislands.com/article/910526308-bayridge-counselling-centres-and-no-fear-counselling-corp-merge-under-ch-y-qtel-wellness-to-form-canada-s-largest-first-nation-s-owned-mental-health Health Times Virgin Islands en PressRelease 2026-05-05T14:00:00+00:00 Bayridge Counselling Centres and No Fear Counselling Corp Merge Under Ch’íyáqtel Wellness to Form Canada’s Largest First Nation’s Owned Mental Health Network https://ml.globenewswire.com/media/77b1c55c-807c-4a32-9598-7cafb1ac92c3/small/cw-new-logo-1-png.png https://www.healthtimesvirginislands.com/article/910526359-aafa-leads-group-of-patients-clinicians-asking-congress-to-protect-programs-that-help-people-with-asthma-and-allergies Health Times Virgin Islands en PressRelease 2026-05-05T14:00:00+00:00 AAFA Leads Group of Patients, Clinicians Asking Congress to Protect Programs that Help People with Asthma and Allergies https://ml.globenewswire.com/media/MDUxY2I5MTctZWI2Yy00NGExLThiMDEtNWM5ZjJkZDVhMWMzLTExMDE5NjItMjAyNi0wNS0wNS1lbg==/tiny/Asthma-and-Allergy-Foundation-.png https://www.healthtimesvirginislands.com/article/910526516-lighthouse-autism-center-opening-new-autism-therapy-center-in-mount-pleasant-iowa Health Times Virgin Islands en PressRelease 2026-05-05T13:48:22+00:00 Lighthouse Autism Center Opening New Autism Therapy Center in Mount Pleasant, Iowa https://ml.globenewswire.com/media/e432b138-98bf-4971-921d-61bc5ac70fa7/small/lighthouse-primary-png.png https://www.healthtimesvirginislands.com/article/910526307-featol-introduces-back-brace-support-belt-for-everyday-lower-back-support Health Times Virgin Islands en PressRelease 2026-05-05T13:32:00+00:00 FEATOL Introduces Back Brace Support Belt for Everyday Lower Back Support https://ml.globenewswire.com/media/b68de2c9-db44-424f-ba79-1b88cf5f3338/medium/featol-back-brace-rear-view-with-breathable-lightweight-mesh.png https://www.healthtimesvirginislands.com/article/910517765-alpha-tau-announces-upcoming-podium-presentation-at-the-ahns-12th-international-conference-on-head-and-neck-cancer-showcasing-study-results-of-alpha Health Times Virgin Islands en PressRelease 2026-05-05T13:14:32+00:00 Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910516832-sk-pharmteco-achieves-sbti-validation-for-2040-net-zero-science-based-targets Health Times Virgin Islands en PressRelease 2026-05-05T13:03:00+00:00 SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthtimesvirginislands.com/article/910516701-chemed-corporation-to-present-at-the-bank-of-america-securities-health-care-conference-2026 Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026 https://ml.globenewswire.com/media/1ab951c0-8d76-40e0-bc65-ebeaa1731e66/small/chemed-corp-logo-600x400-jpg.jpg https://www.healthtimesvirginislands.com/article/910516733-karl-jacob-s-fix-your-insulin-hits-1-amazon-best-seller-in-diabetes-category-launches-limited-time-0-99-reader-promotion Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Karl Jacob's "Fix Your Insulin" Hits #1 Amazon Best Seller in Diabetes Category, Launches Limited-Time $0.99 Reader Promotion https://pressranger.s3.us-west-1.amazonaws.com/3242430/The-Insulin-Fix_Cover-6.jpg https://www.healthtimesvirginislands.com/article/910516841-heartsciences-signs-first-saas-revenues-agreement-following-full-launch-of-myovista-insights Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ https://ml.globenewswire.com/media/800a6aae-74f3-42bb-9199-5e169ed9b881/small/heartsciences-png.png https://www.healthtimesvirginislands.com/article/910517024-precision-optics-announces-receipt-of-3-5-million-follow-on-production-order-for-single-use-ophthalmic-program Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910517058-bicycle-health-expands-leadership-team-to-increase-access-to-evidence-based-opioid-use-disorder-care Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Bicycle Health Expands Leadership Team to Increase Access to Evidence-Based Opioid Use Disorder Care https://ml.globenewswire.com/media/ba03cedc-3d11-4aa5-b226-cb5784309493/small/copy-of-bhvirtualcarelogo-black-2x-jpg.jpg https://www.healthtimesvirginislands.com/article/910517073-maps-state-of-colorado-partner-to-deliver-free-harm-reduction-training-for-first-responders Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 MAPS & State of Colorado Partner to Deliver Free Harm Reduction Training for First Responders https://ml.globenewswire.com/media/4f774750-4742-4818-be22-116e2b2085b1/small/maps-logo-2021-primary-horizontal-white-background-1200x486.jpg https://www.healthtimesvirginislands.com/article/910517086-femasys-enables-ob-gyns-to-deliver-first-line-fertility-treatment-with-initial-commercial-use-of-femaseed-complete Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://www.healthtimesvirginislands.com/article/910517333-health-canada-authorizes-north-america-s-first-hepatitis-b-rapid-test-biolytical-s-istatis-hepatitis-b-surface-antigen-test Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Health Canada Authorizes North America’s First Hepatitis B Rapid Test, bioLytical’s iStatis Hepatitis B Surface Antigen Test https://ml.globenewswire.com/media/8c4f4c4f-8565-4ee5-9842-ca4d0dcf67fb/medium/istatis-hepatitis-b-surface-antigen-test.jpg https://www.healthtimesvirginislands.com/article/910517373-biosphere-awarded-9-million-u-s-army-contract-to-develop-on-demand-nutrition-production-system-for-warfighters Health Times Virgin Islands en PressRelease 2026-05-05T13:00:00+00:00 Biosphere Awarded $9 Million U.S. Army Contract to Develop On-Demand Nutrition Production System for Warfighters https://ml.globenewswire.com/media/e816f42d-d6f4-462f-a3af-65eb8d733841/small/logo1-png.png https://www.healthtimesvirginislands.com/article/910516816-cellution-biologics-celebrates-expansion-of-u-s-headquarters-in-roswell-georgia Health Times Virgin Islands en PressRelease 2026-05-05T12:55:00+00:00 Cellution Biologics Celebrates Expansion of U.S. Headquarters in Roswell, Georgia https://ml.globenewswire.com/media/25f5b530-a1f5-4314-a4b9-9d2a0ec2a934/small/cb-logo-colorfs-png.png https://www.healthtimesvirginislands.com/article/910517494-clearmind-medicine-announces-filing-of-european-patent-application-for-novel-psychedelic-compounds-for-the-treatment-of-ptsd Health Times Virgin Islands en PressRelease 2026-05-05T12:50:00+00:00 Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910517538-clene-announces-7-million-underwritten-offering-of-common-stock Health Times Virgin Islands en PressRelease 2026-05-05T12:45:00+00:00 Clene Announces $7 Million Underwritten Offering of Common Stock https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://www.healthtimesvirginislands.com/article/910507674-ocugen-provides-business-update-with-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T12:32:54+00:00 Ocugen Provides Business Update with First Quarter 2026 Financial Results https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.healthtimesvirginislands.com/article/910506917-sab-bio-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-may-12-2026-08-30-am-et Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://www.healthtimesvirginislands.com/article/910507058-ss-innovations-surpasses-10-500-surgeries-performed-with-the-ssi-mantra-surgical-robotic-system Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System https://ml.globenewswire.com/media/cef267e0-040f-4889-a706-cc4d0ae49e55/small/new-logo-april-23-2025-png.png https://www.healthtimesvirginislands.com/article/910507118-achieve-life-sciences-to-announce-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-may-12-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://www.healthtimesvirginislands.com/article/910507145-sofwave-medical-reports-first-quarter-fiscal-2026-financial-results-and-business-highlights Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Sofwave Medical Reports First Quarter Fiscal 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/9fbd88c7-2eaf-45c3-b046-2d055fe94a07/small/download-png.png https://www.healthtimesvirginislands.com/article/910507153-disc-medicine-reports-first-quarter-2026-financial-results-and-provides-business-update Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910507252-palisade-bio-reports-additional-phase-1a-b-data-demonstrating-colon-targeted-exposure-and-sustained-ic90-coverage-supporting-once-daily-dosing-in Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png https://www.healthtimesvirginislands.com/article/910507258-cormedix-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-a-corporate-update-on-may-14-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026 https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507278-fate-therapeutics-selected-for-u-s-fda-chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-to-support-manufacturing Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819 https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.healthtimesvirginislands.com/article/910507452-oragenics-activates-second-site-in-phase-iia-clinical-trial-of-onp-002-for-concussion-and-mild-traumatic-brain-injury Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury. https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507457-profusa-initiates-board-led-process-to-evaluate-strategic-alternatives-and-maximize-shareholder-value Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507458-imunon-to-hold-first-quarter-2026-financial-results-and-business-update-conference-call-on-tuesday-may-12-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026 https://ml.globenewswire.com/media/acf78e45-a45b-456b-93e3-0e39f2122826/small/logo-png.png https://www.healthtimesvirginislands.com/article/910507620-microbot-medical-s-liberty-endovascular-robotic-system-is-now-adopted-by-multiple-accounts-across-key-territories-including-two-access-pvi-pivotal Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.healthtimesvirginislands.com/article/910507662-fibrobiologics-ceo-issues-letter-to-shareholders Health Times Virgin Islands en PressRelease 2026-05-05T12:30:00+00:00 FibroBiologics CEO Issues Letter to Shareholders https://ml.globenewswire.com/media/f3ebedd0-66f2-4e20-b298-4b52bbb42404/medium/pete-o-heeron.jpg https://www.healthtimesvirginislands.com/article/910507657-ocugen-inc-announces-pricing-of-115-million-of-6-75-convertible-senior-notes Health Times Virgin Islands en PressRelease 2026-05-05T12:12:21+00:00 Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.healthtimesvirginislands.com/article/910507636-blood-banking-devices-market-size-to-surpass-usd-9-08-bn-by-2034-driven-by-rising-number-of-blood-banks-globally Health Times Virgin Islands en PressRelease 2026-05-05T12:06:12+00:00 Blood Banking Devices Market Size to Surpass USD 9.08 BN by 2034, Driven by Rising Number of Blood Banks Globally https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.healthtimesvirginislands.com/article/910507192-noom-names-power-of-habit-author-charles-duhigg-as-advisor-releases-new-research-linking-glp-1-success-to-habit-formation Health Times Virgin Islands en PressRelease 2026-05-05T12:02:00+00:00 Noom Names “Power of Habit” Author Charles Duhigg as Advisor, Releases New Research Linking GLP-1 Success to Habit Formation https://ml.globenewswire.com/media/6b8c0d7a-2154-4867-82d3-f7e88a9793ee/medium/noom-psychosocial-report-findings.jpg https://www.healthtimesvirginislands.com/article/910506877-allarity-therapeutics-advances-stenoparib-toward-pivotal-development-with-phase-3-manufacturing-campaign Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Allarity Therapeutics Advances Stenoparib Toward Pivotal Development with Phase 3 Manufacturing Campaign https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://www.healthtimesvirginislands.com/article/910506884-spyre-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.healthtimesvirginislands.com/article/910506912-nu-tek-biosciences-presents-data-driven-approach-to-animal-cell-culture-optimization-at-esact-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Nu-Tek BioSciences Presents Data-Driven Approach to Animal Cell Culture Optimization at ESACT 2026 https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://www.healthtimesvirginislands.com/article/910506922-nu-tek-biosciences-pr-sentiert-auf-der-esact-2026-einen-datengest-tzten-ansatz-zur-optimierung-der-tierischen-zellkultur Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Nu-Tek BioSciences präsentiert auf der ESACT 2026 einen datengestützten Ansatz zur Optimierung der tierischen Zellkultur https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://www.healthtimesvirginislands.com/article/910506928-nu-tek-biosciences-pr-sente-une-approche-fond-e-sur-les-donn-es-pour-l-optimisation-de-la-culture-de-cellules-animales-lors-de-l-esact-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Nu-Tek BioSciences présente une approche fondée sur les données pour l’optimisation de la culture de cellules animales lors de l’ESACT 2026 https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://www.healthtimesvirginislands.com/article/910506939-healthverity-to-acquire-symphony-health-uniting-clinical-data-and-commercial-analytics-to-accelerate-breakthroughs-across-the-healthcare-ecosystem Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem https://ml.globenewswire.com/media/e2010eff-0993-44c1-a40d-9f0237268a35/medium/healthverity.jpg https://www.healthtimesvirginislands.com/article/910506952-septerna-to-present-at-bank-of-america-securities-health-care-conference Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Septerna to Present at Bank of America Securities Health Care Conference https://ml.globenewswire.com/media/8c635733-2794-456f-9bc4-3b53908acba9/small/septernalogo-black-10x-jpg.jpg https://www.healthtimesvirginislands.com/article/910507011-transplants-org-launches-as-centralized-education-and-navigation-platform-for-organ-and-stem-cell-transplant-patients Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Transplants.org Launches as Centralized Education and Navigation Platform for Organ and Stem Cell Transplant Patients https://ml.globenewswire.com/media/1d980326-1679-4adb-bd02-7e4358b841ce/small/transplants-org-logo-color-jpg.jpg https://www.healthtimesvirginislands.com/article/910507047-clene-to-present-at-upcoming-may-conferences Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Clene to Present at Upcoming May Conferences https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://www.healthtimesvirginislands.com/article/910507089-geron-plans-to-present-at-upcoming-investor-conferences Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Geron Plans to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507095-minerva-neurosciences-provides-first-quarter-2026-financial-results-and-business-updates Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/69e604cb-25b6-4235-ae9a-17c25cc158b9/small/minerva-logo.jpg https://www.healthtimesvirginislands.com/article/910507163-cg-oncology-to-present-at-upcoming-investor-conferences-in-may Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 CG Oncology to Present at Upcoming Investor Conferences in May https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://www.healthtimesvirginislands.com/article/910507196-corbus-pharmaceuticals-to-host-in-person-and-virtual-kol-event-at-asco-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026 https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507205-zentalis-pharmaceuticals-announces-first-patient-dosed-in-aspenova-phase-3-trial-of-azenosertib-in-patients-with-cyclin-e1-positive-platinum-resistant Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.healthtimesvirginislands.com/article/910507214-picard-medical-announces-pricing-of-5-million-offering Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Picard Medical Announces Pricing of $5 Million Offering https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.healthtimesvirginislands.com/article/910507244-filana-therapeutics-presents-tsc-related-epilepsy-program-at-eilat-xviii Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII https://ml.globenewswire.com/media/984a6554-2b2a-4cf7-9a32-72ac808d52ac/small/filana400-png.png https://www.healthtimesvirginislands.com/article/910507247-madrigal-adds-clinical-stage-sirna-asset-targeting-pnpla3-to-its-mash-pipeline Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507268-pathai-and-a-c-camargo-cancer-center-announce-cooperation-to-expand-digital-pathology-with-ai-in-brazil-via-sus Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 PathAI and A.C.Camargo Cancer Center Announce Cooperation to Expand Digital Pathology with AI in Brazil via SUS https://ml.globenewswire.com/media/ab2bfc12-ae80-47c6-9345-a98783489ed7/small/pathai-logo-standard-png.png https://www.healthtimesvirginislands.com/article/910507406-cogent-biosciences-reports-recent-business-highlights-and-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.healthtimesvirginislands.com/article/910507408-verrica-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-a-corporate-update-on-may-12-2026 Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026 https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507428-bionano-announces-a-56-increase-in-publications-describing-the-utility-of-ogm-in-rare-diseases-in-q1-2026-vs-q1-2025 Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.healthtimesvirginislands.com/article/910507624-mineralys-therapeutics-to-participate-in-the-bank-of-america-securities-health-care-conference Health Times Virgin Islands en PressRelease 2026-05-05T12:00:00+00:00 Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.healthtimesvirginislands.com/article/910507632-latest-digestive-health-supplements-market-size-expected-to-reach-usd-25-86-billion-by-2034-with-6-10-cagr-driven-by-rising-geriatric-population Health Times Virgin Islands en PressRelease 2026-05-05T11:59:13+00:00 [Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.healthtimesvirginislands.com/article/910507208-neuronetics-reports-first-quarter-2026-financial-and-operating-results Health Times Virgin Islands en PressRelease 2026-05-05T11:50:00+00:00 Neuronetics Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://www.healthtimesvirginislands.com/article/910497076-discure-technologies-appoints-dr-ray-baker-to-its-board-of-directors Health Times Virgin Islands en PressRelease 2026-05-05T11:35:00+00:00 Discure Technologies Appoints Dr. Ray Baker to its Board of Directors https://ml.globenewswire.com/media/eb02cf21-747a-4619-8cb2-b3929c46ae7e/small/descure-technologies-logo-png.PNG https://www.healthtimesvirginislands.com/article/910497087-kura-oncology-to-report-first-quarter-2026-financial-results Health Times Virgin Islands en PressRelease 2026-05-05T11:30:00+00:00 Kura Oncology to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.healthtimesvirginislands.com/article/910497096-intellia-therapeutics-to-participate-in-upcoming-investor-conferences Health Times Virgin Islands en PressRelease 2026-05-05T11:30:00+00:00 Intellia Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.healthtimesvirginislands.com/article/910497121-compass-therapeutics-reports-2026-first-quarter-financial-results-and-provides-corporate-update Health Times Virgin Islands en PressRelease 2026-05-05T11:30:00+00:00 Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update  https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.healthtimesvirginislands.com/article/910497160-bridgebio-to-present-primary-results-from-the-phase-3-calibrate-trial-at-2026-ece Health Times Virgin Islands en PressRelease 2026-05-05T11:30:00+00:00 BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png